Viewing Study NCT03232593


Ignite Creation Date: 2025-12-25 @ 1:02 AM
Ignite Modification Date: 2026-01-02 @ 11:57 PM
Study NCT ID: NCT03232593
Status: COMPLETED
Last Update Posted: 2022-08-24
First Post: 2017-07-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module